Skip to main content
. 2017 May 26;25(7):1097–1102. doi: 10.1016/j.jsps.2017.05.006

Table 1A.

The activity data expressed as MIC (MBC or MFC) [µg/ml] and {MBC/MIC or MFC/MIC ratio} against the reference strains of microorganisms. The standard chemotherapeutics agents: nitrofurantoin (NIT), ciprofloxacin (CIP), cefuroxime (CFX) and fluconazole (FLU) were used as positive control.

Species MIC (MBC or MFC) [µg/ml] and {MBC/MIC or MFC/MIC ratio} of the tested compounds
28 29 30 31 32 33 34 35 36 37 38 NIT CIP CFX FLU
Gram-positive bacteria Staphylococcus
aureus
ATCC 25923
7.81
(7.81)
{1}
7.81
(7.81)
{1}
15.62
(125)
{8}
31.25
(250)
{8}
3.91
(7.81)
{2}
1.95
(3.91)
{2}
1.95
(15.62)
{8}
3.91
(7.81)
{2}
3.91
(3.91)
{1}
3.91
(7.81)
{2}
0.061
(7.81)
{128}
15.62
(15.62)
0.488 0.49 na
Staphylococcus
aureus
ATCC 6538
7.81
(7.81)
{1}
7.81
(7.81)
{1}
31.25
(62.5)
{2}
31.25
(62.5)
{2}
3.91
(7.81)
{2}
3.91
(3.91)
{1}
0.98
(3.91)
{4}
3.91
(7.81)
{2}
1.95
(3.91)
{2}
7.81
(15.62)
{2}
0.98
(1.95)
{2}
15.62
(15.62)
0.244 0.98 na
Staphylococcus
aureus
ATCC 43300
0.98
(3.91)
{4}
1.95
(3.91)
{2}
7.81
(15.62)
{2}
7.81
(15.62)
{2}
0.98
(1.95)
{2}
0.244
(0.488)
{2}
0.244
(0.488)
{2}
1.95
(3.91)
{2}
0.488
(0.98)
{2}
7.81
(15.62)
{2}
0.122
(0.244)
{2}
7.81
(15.62)
0.244 nd na
Staphylococcus
epidermidis
ATCC 12228
0.98
(1.95)
{2}
0.98
(1.95)
{2}
3.91
(15.62)
{4}
3.91
(15.62)
{4}
0.061
(0.244)
{4}
0.061
(0.122)
{2}
0.244
(0.488)
{2}
0.48
(0.98)
{2}
0.061
(0.122)
{2}
0.244
(0.244)
{1}
0.002
(0.002)
{1}
3.91
(7.81)
0.122 0.24 na
Micrococcus
luteus
ATCC 10240
62.5
(125)
{2}
62.5
(250)
{4}
250
(1000)
{4}
62.5
(500)
{8}
62.5
(62.5)
{1}
500
(>1000)
{>2}
250
(>1000)
{>4}
250
(>1000)
{>4}
62.5
(125)
{2}
1000 (>1000)
{>1}
125
(125)
{1}
62.5
(62.5)
0.976 0.98 na
Bacillus
subtilis
ATCC 6633
0.98
(0.98)
{1}
1.95
(1.95)
{1}
3.91
(7.81)
{2}
3.91
(7.81)
{2}
0.002
(0.008)
{1}
0.244
(7.81)
{32}
0.98
(3.91)
{4}
1.95
(1.95)
{1}
3.91
(3.91)
{1}
1.95
(1.95)
{1}
0.244
(0.98)
{4}
3.91
(3.91)
0.031 15.63 na
Bacillus
cereus
ATCC 10876
7.81
(7.81)
{1}
7.81
(7.81)
{1}
31.25
(31.25)
{1}
62.5
(125)
{2}
0.98
(3.91)
{4}
3.91
(7.81)
{2}
0.98
(15.62)
{16}
3.91
(3.91)
{1}
1.95
(3.91)
{2}
1.95
(1.95)
{1}
0.488
(0.98)
{2}
7.81
(15.62)
0.061 31.25 na



Gram-negative
bacteria
Bordetella bronchiseptica
ATCC 4617
31.25
(125)
{4}
62.5
(500)
{8}
125
(500)
{4}
62.5
(250)
{4}
500
(>1000)
{>2}
500
(>1000)
{>2}
125
(1000)
{8}
1000
(>1000)
{>1}
125
(>1000)
0.976 nd na
Klebsiella
pneumoniae ATCC 13883
7.81
(15.62)
{2}
7.81
(7.81)
{1}
125
(250)
{2}
125
(125)
{1}
31.25
(>1000)
{>32}
1000
(>1000)
{>1}
125
(500)
{4}
15.62
(31.25)
0.122 nd na
Proteus
mirabilis
ATCC 12453
31.25
(62.5)
{2}
62.5
(125)
{2}
500
(1000)
{2}
250
(500)
{2}
250
(>1000)
{>4}
250
(>1000)
{>4}
62.5
(250)
{4}
62.5
(125)
0.030 nd na
Salmonella typhimurium
ATCC 14028
7.81
(7.81)
{1}
7.81
(7.81)
{1}
125
(500)
{4}
62.5
(125)
{2}
0.98
(7.81)
{8}
500
(>1000)
{>2}
62.5
(250)
{4}
31.25
(62.5)
0.061 nd na
Escherichia
coli
ATCC 25922
7.81
(7.81)
{1}
3.91
(7.81)
{2}
125
(250)
{2}
62.5
(125)
{2}
0.98
(1.95)
{2}
1000
(>1000)
{>1}
31.25
(31.25)
{1}
7.81
(15.62)
0.004 nd na
Pseudomonas aeruginosa
ATCC 9027
500
(1000)
{2}
250
(500)
{2}
62.5
(125)
{2}
0.488 nd na



Fungi Candida albicans
ATTC 10231
125
(250)
{2}
500
(>1000)
125
(500)
{4}
62.5
(125)
{2}
500
(>1000)
{>2}
125
(>1000)
{>8}
250
(>1000)
{>4}
31.25
(62.5)
{2}
125
(250)
{2}
1000
(>1000)
{>1}
na na na 0.98
Candida parapsilosis
ATTC 22019
250
(500)
{2}
1000
(>1000)
{>1}
125
(1000)
{8}
62.5
(250)
{4}
1000
(>1000)
{>1}
500
(>1000)
{>2}
500
(>1000)
{>2}
125
(1000)
{8}
1000
(>1000)
{>1}
1000
(>1000)
{>1}
na na na 1.95

na - not applicable; nd – not determined; ‘-’ – no activity; MIC – Minimal Inhibitory Concentration; MBC – Minimal Bactericidal Concentration; MFC - Minimal Fungicidal Concentration; Compounds with bactericidal effect (MBC/MIC ≤ 4) or fungicidal effect (MFC/MIC ≤ 4) are marked in bold.